Methyl 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate
Product Description
Shandong Boyuan Pharmaceutical Co., Ltd.
-
Country/Region:China
-
On CPHI since:2025
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
Categories
Specifications
Shandong Boyuan Pharmaceutical Co., Ltd.
-
Country/Region:China
-
On CPHI since:2025
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
More Products from Shandong Boyuan Pharmaceutical Co., Ltd. (99)
-
Product Cis-Hexahydroisoindoline Hydrochloride
Mitiglinide Calcium Intermediate -
Product Diethyl 1,3-acetonedicarboxylate
Strontium Ranelate Intermediate -
Product Ethyl 2-aminothiazole-5-carboxylate
Dasatinib Intermediate -
Product Methyl 2-(bromo methyl)-3-nitrobenzoate
Lenalidomide Intermediate -
Product Methyl 4-chloro-7-Methoxyquinoline-6-carboxylate
Lenvatinib Intermediate -
Product N-(2-Pyrazinylcarbonyl)-L-phenylalanine
Bortezomib Intermediate -
Product N-(2',6'-Dimethylphenyl)-2-Piperidinecarboxamide
Ropivacaine Intermediate -
Product N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine
Enzalutamide Intermediate -
Product N,N,N'-Trimethylethylenediamine
Osimertinib Intermediate -
Product L-Glutamic Acid Diethyl Ester Hydrochloride
Pemetrexed Disodium Intermediate
![Carbamic acid, N-[(6S)-2-(acetylamino)-4,5,6,7-tetrahydro-6-benzothiazolyl]-, 1-methylethyl ester](https://www.cphi-online.com/img/v2021/product_image.png)